No Data
No Data
Tonix Pharmaceuticals Announces Grant by Medical CBRN Defense Consortium (MCDC) for Development of TNX-801, the Company's Single-Dose Mpox and Smallpox Vaccine Candidate
Express News | Tonix Pharmaceuticals: Tolerability of Tnx‐801 Vaccination in Immune-Compromised Animal Models Supports Clinical Development
Express News | Tonix Pharmaceuticals Announces Grant by Medical Cbrn Defense Consortium (Mcdc) for Development of Tnx-801, the Company’s Single-Dose Mpox and Smallpox Vaccine Candidate
Tonix Pharmaceuticals (TNXP) Stock Rises Sharply
Tonix Pharmaceuticals to Present at the 2025 Virtual Investor Summit
Tonix Pharmaceuticals Presents Phase 3 Data On TNX-102 SL For Fibromyalgia At International Congress